Improving the evaluation of new cancer therapies to expedite patient access

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1128332

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

The government funds cancer drugs, but drugs have to provide value for money to Australian taxpayers. Most proposed cancer drugs provide a benefit to patients but reaching agreement on how much the government will pay for these drugs often delays access by months, and often over a year due to uncertainty regarding drugs’ long-term effects. This research will test methods and develop guidelines to reduce this uncertainty and provide earlier access to new cancer drugs.

Funded Activity Details

Start Date: 01-01-2017

End Date: 01-01-2018

Funding Scheme: Project Grants

Funding Amount: $412,888.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Oncology and Carcinogenesis not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cancer therapy | clinical trial | oncology | statistics | survival analysis

Related Links